important information for the patient.
Luivac is an immunostimulating agent used orally.
The antigenic structures present in Luivac are absorbed by the gastrointestinal tract epithelium and enter the cells of the immune system in the gastrointestinal tract area. This leads to the stimulation of defense mechanisms throughout the mucosal immune system, including the bronchial tree.
Indications for use:
Adults
Prevention of recurrent respiratory tract infections (RTI) in adults..
Children and adolescents
Prevention of recurrent respiratory tract infections (RTI) in children from 4 years of age.
Due to insufficient experience and the possibility of complex interactions, the medicine should not be used
in patients with autoimmune diseases.
Before starting to use Luivac, discuss it with your doctor or pharmacist.
It is not recommended to use Luivac to prevent pneumonia, as there are no clinical trial data confirming such an effect.
As with any non-specific immunotherapy, it is not recommended to use specific vaccinations at the same time.
Luivac should not be given to children under 4 years of age.
Tell your doctor or pharmacist about all medicines you are taking, or have recently taken, and about any medicines you plan to take.
No interactions with other medicines have been found.
In patients undergoing immunosuppressive treatment, the response to vaccination may be weakened.
Tablets should be swallowed on an empty stomach, with a small amount of liquid.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. Due to the lack of data, the medicine should not be used in pregnant women.
No contraindications to the use of Luivac during breastfeeding.
Luivac does not affect the ability to drive and use machines.
This medicine should always be used as directed by your doctor or pharmacist. In case of doubts, consult your doctor or pharmacist.
The recommended dose is
Luivac should be taken for 28 consecutive days in two cycles separated by a 28-day break.
Tablets should be swallowed on an empty stomach, with a small amount of liquid.
Treatment with Luivac usually starts during a period free from infection. In the case of an acute infection, Luivac may be used at the same time as antibiotics, but it cannot replace anti-inflammatory treatment.
No cases of overdose have been reported.
Do not take a double dose to make up for a missed dose of Luivac.
In case of any further doubts about the use of this medicine, consult your doctor or pharmacist.
Like all medicines, Luivac can cause side effects, although not everybody gets them.
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 10,000 people)
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products:
Al. Jerozolimskie 181 C,
02-222 Warsaw,
Phone: +48 22 49 21 301,
Fax: +48 22 49 21 309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
No special precautions for storage of the medicinal product.
Protect from light.
Do not use this medicine after the expiry date stated on the carton and blister after "EXP".
The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
1 tablet contains:
Active substance LW50020R
43 mg
lysate of bacteria of each of the following strains
3 mg
(each strain at least 1 x 10 microorganisms):
Staphylococcus aureus,
Streptococcus mitis,
Streptococcus pyogenes,
Streptococcus pneumoniae,
Klebsiella pneumoniae,
Moraxella (Branhamella) catarrhalis
Haemophilus influenzae
mannitol
40 mg
Other ingredients are: mannitol, microcrystalline cellulose, glycolic starch (type A), magnesium stearate, anhydrous colloidal silica
Blisters: lower part consisting of three layers: polyamide film, aluminum foil, PVC film;
upper part: aluminum foil coated with a transparent protective layer.
Packs contain 28 tablets (2 blisters) or 56 tablets (4 blisters).
Zentiva k.s.
U kabelovny 130
Dolní Měcholupy
102 37 Prague 10
Czech Republic
Daiichi Sankyo Europe GmbH
Luitpoldstrasse 1, 85276 Pfaffenhofen/Ilm, Germany
Zentiva Polska Sp. z o.o.
ul. Bonifraterska 17
00-203 Warsaw
phone: +48 22 375 92 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.